Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gossamer Bio (GOSS) Other Non Operating Income: 2018-2024

Historic Other Non Operating Income for Gossamer Bio (GOSS) over the last 7 years, with Dec 2024 value amounting to $14.0 million.

  • Gossamer Bio's Other Non Operating Income fell 31.11% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.4 million, marking a year-over-year decrease of 8.90%. This contributed to the annual value of $14.0 million for FY2024, which is 9.28% down from last year.
  • Gossamer Bio's Other Non Operating Income amounted to $14.0 million in FY2024, which was down 9.28% from $15.5 million recorded in FY2023.
  • Over the past 5 years, Gossamer Bio's Other Non Operating Income peaked at $15.5 million during FY2023, and registered a low of -$174,000 during FY2020.
  • For the 3-year period, Gossamer Bio's Other Non Operating Income averaged around $10.3 million, with its median value being $14.0 million (2024).
  • In the last 5 years, Gossamer Bio's Other Non Operating Income crashed by 107.88% in 2020 and then surged by 922.22% in 2023.
  • Over the past 5 years, Gossamer Bio's Other Non Operating Income (Yearly) stood at -$174,000 in 2020, then skyrocketed by 559.20% to $799,000 in 2021, then spiked by 89.24% to $1.5 million in 2022, then spiked by 922.22% to $15.5 million in 2023, then fell by 9.28% to $14.0 million in 2024.